Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing elpipodect for schizophrenia.
In United StatesThis study is completed in the United States. It is testing esketamine Nasal Spray, Administered for treatment-resistant depression.
In United StatesThis study is completed in the United States. It is testing flexible Dose Brexpiprazole for PTSD.
In United StatesThis study is completed in the United States. It is testing infliximab for depression.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.
In United StatesThis study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
In United StatesThis study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-61393215 for depression.
In United StatesThis study is completed in the United States. It is testing JZP150 for PTSD.
In United StatesThis study was terminated in the United States. It focuses on Bipolarity.
In United StatesThis study is completed in the United States. It is testing ketamine for treatment-resistant depression.
In United States
This study is completed in the United States. It is testing label Compliance for ADHD.
In United StatesThis study was terminated in the United States, in Mexico, in Russia, .... It is testing LY2140023 for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.